Patent Grant
11786182
Advances in software, electronics, sensor technology and materials science have revolutionized patient monitoring technologies. In particular, many devices and systems are becoming available for a variety of health monitoring applications. However, improvements may yet be desired for health monitoring devices and systems that provide one or more of effective data collection and/or manipulation for parameter determination.
Further alternatives for patients and their physicians may then be developed to include robust and convenient monitors that in some instances may collect and transfer long-term data as well as monitor events in real-time, including multi-variable parameter determination.
Described herein are several alternative medical monitoring devices, systems and/or methods for parameter determination, in some instances for long-term sensing and/or recording of cardiac and/or respiratory data of an individual, such as a neonate, athlete, or cardiac patient. A number of alternative implementations and applications are summarized and/or exemplified herein below and throughout this specification.
In one alternative aspect, the developments hereof may include an implementation wherein a health device is configured for monitoring a plurality of physiological parameters of an individual from time-concordant measurements collected by one or a plurality of sensors, including a variety of one or more of, but not limited to, electrodes for measuring ionic potential changes for electrocardiograms (ECGs), a light source and one or more photodetectors, such as LED-photodiode pairs, for optically based oxygen saturation measurements, a temperature sensor, an xyz accelerometer for movement and exertion measurements, and the like. In some implementations, methods and devices of the developments hereof may be used to generate a respiration waveform. Other implementations may include a circuit that mimics a driven right-leg circuit (sometimes referred to herein as “a proxy driven right-leg circuit”) that may permit reduction in common mode noise in a small-footprint device conveniently adhered or having the capacity to be adhered to an individual.
In another alternative aspect hereof, a blood pressure determination may be made from a determination of pulse transit time. The pulse transit time is the time for the cardiac pressure wave to travel from the heart to other locations in the body. Measurements of pulse transit time may then be used to estimate blood pressure. Heart beat timing from ECG or otherwise and photoplethysmogram (aka PPG) signals can be used to generate pulse transit time. Note, such signals may be generated from conventional or other to-be-developed processes and/or devices or systems; or, such signals may be taken from one or more wearable health monitoring devices such as those also described hereinbelow.
In another alternative aspect, the developments hereof may include one or more methods and/or devices for measuring and/or determining oxygen saturation parameters from time concordant pulse oximetry signals and ECG signals. In one implementation, ECG signals may be used to define intervals, or “frames” of pulse oximetry data that are collected and averaged for determining the constant and main periodic components (e.g., DC and AC components) of the pulse oximetry signals from which, in turn, values for oxygen saturation may be determined. Patient-wearable devices of such implementations with pulse oximetry and ECG sensors may be particularly useful when placed on a patient's chest for such signal acquisition.
These as well as other alternative and/or additional aspects are exemplified in a number of illustrated alternative and/or additional implementations and applications, some of which are shown in the figures and characterized in the claims section that follows. However, as will be understood by the ordinarily skilled artisan, the above summary and the detailed description below do not describe the entire scope of the inventions hereof and are indeed not intended to describe each illustrated embodiment or every implementation of the present inventions nor provide any limitation on the claims or scope of protection herein set forth below.
The drawings include:
While the inventions hereof are amenable to various modifications and alternative forms, specifics thereof have been shown herein by way of example in the drawings and the following description. It should be understood, however, that the intention is not to limit the inventions to the particular embodiments described. The intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the inventions whether described here or otherwise being sufficiently appreciable as included herewithin even if beyond the literal words hereof.
In one aspect, a system hereof may include a device for monitoring physiological parameters such as one or more or all of electrocardiogram (aka ECG or EKG), photoplethysmogram (aka PPG), pulse oximetry, temperature and/or patient acceleration or movement signals.
Moreover, systems hereof may be established to measure and/or process such signals of a patient using or including one or more of the following elements: (a) a circuit, sometimes flexible as in or on or forming a flexible or flex circuit board, embedded in or on a flat elastic substrate or board having a top surface and a bottom surface, the circuit having one or more of (i) at least one sensor mounted in or on or adjacent the bottom surface of the flat elastic substrate, the at least one sensor being capable of electrical or optical communication with the patient, (ii) at least one signal processing module for receiving and/or accepting signals from the at least one sensor in some implementations also providing for transforming such signals for storage as patient data; (iii) at least one memory module for receiving and/or accepting and storing patient data, (iv) at least one data communication module for transferring patient data, stored or otherwise to an external device, and (v) a control module for controlling the timing and operation of the at least one sensor, one or more of the at least one signal processing module, the at least one memory module, the at least one data communication module, and/or the control module capable of receiving commands to implement transfer of patient data by the at least one data communication module and to erase and/or wipe patient data from the at least one memory module; and (b) a conductive adhesive removably attached to the bottom surface of the flat elastic substrate, the conductive adhesive capable of adhering to skin of the patient and of conducting an electrical signal substantially only in a direction perpendicular to the bottom surface of the flat elastic substrate, and/or in some implementations including a conductive portion adjacent the sensor or sensors and a non-conductive portion. In some implementations, the conductive adhesive is an anisotropically conductive adhesive in that it comprises regions of material that conducts current substantially only in a direction perpendicular to the skin (i.e. “z-axis” conduction).
In some implementations, devices hereof will be for comprehensive long-term cardiac monitoring, inter alia. Features of such may include one or more of a Lead 1 ECG, PPG, pulse oximeter, accelerometer, temperature sensor and/or a button or other indicator for manual patient event marking. Such a device may be adapted to store up to, for example, about two weeks of continuous data (though more or less will also be feasible in alternative implementations), which may in some implementations be downloaded to a clinic or other computer in a short time period, as for one example, in only about 90 seconds (though more or less time will be viable in alternative implementations) via computer connection, whether wireless or wired as in one example by USB or other acceptable data connection. A companion software data analysis package may be adapted to provide automated event capture and/or allow immediate or delayed, local data interpretation.
Intermittent cardiac anomalies are often difficult for physicians to detect and/or diagnose, as they would typically have to occur during a physical examination of the patient. A device hereof may address this problem with what in some implementations may be a continuous or substantially continuous monitoring of one or a number of vital signs.
Some alternative features may include one or more of (i) a driven “Right Leg” circuit with electrodes located only on the chest, (ii) a “z-Axis” or anisotropic conductive adhesive electrode interface that may permit electrical communication only between an electrode and a patient's skin immediately beneath the electrode, (iii) data transmission to and interpretation by a local computer accessible to CCU/ICU personnel, (iv) a unique combination of hardware that may allow correlation of multiple data sources in time concordance to aid in diagnosis.
In some alternative implementations, devices and systems hereof may provide 1) reusability (in some cases near or greater than about 1000 patients) that may allow recouping cost of the device in just about 10-15 patient tests; 2) one or more of ECG waveform data, inertial exertion sensing, manual event marking, temperature sensing and/or pulse oximetry, any or all of which in time concordance to better detect and analyze arrhythmic events; 3) efficient watertightness or waterproofing (for the patient/wearer to be able to swim while wearing the device); and 4) a comprehensive analysis package for typically immediate, local data interpretation. An alternative device may be adapted to take advantage of flex-circuit technology, to provide a device that is light-weight, thin, durable, and flexible to conform to and move with the patient's skin during patient/wearer movement.
Many of the electronics hereof may be disposed in the electronics layer or layers 103, and as generally indicated here, the electronics may be encapsulated in a material 104 (see
The elongated strip layer 105 may be or may include a circuit or circuit portions such as electrical leads or other inner layer conductors, e.g., leads 107 shown in
On the patient side 102, the ECG electrodes 108, 109 and 110 may be left exposed for substantially direct patient skin contact (though likely with at least a conductive gel applied therebetween); and/or, in many implementations, the patient side electrodes 108, 109 and/or 110 may be covered by a conductive adhesive material as will be described below. The electrodes may be plated with or may be a robust high conductive material, as for example, silver/silver chloride for biocompatibility and high signal quality, and in some implementations may be highly robust and, for one non-limiting example, be adapted to withstand over about 1000 alcohol cleaning cycles between patients. Windows or other communication channels or openings 111, 112 (
In some implementations, sampling of the ambient light (with the LEDs off) may be provided, and then subtracting this from each of the pulse-ox signals in order to cancel out the noise caused by sunlight or other ambient light sources.
The LEDs and photodiode sensor may also and/or alternatively be covered with a layer of silicone to remove any air gap between the sensor/LEDs and the patient skin. Two examples of such are set forth in respective
In one or more implementations, a lens 121/121a/121b hereof may be made from a medical grade silicone that is one or more of clear, colorless, soft, low durometer. Exemplars of such specialized silicones that may be used herewith are known as “tacky gels” (several suppliers), and typically have very high-tack adhesives, preferably embedded on both sides. A low durometer silicone combined with double-sided adhesive on the tacky gel allows the construction of a lens 121/121a/121b that may be both conforming to the electronic sensors and skin, as well as, in some implementations, exhibiting properties of motion artifact reduction by limiting movement between the skin-lens-sensor interface. A lens according hereto may also/alternatively be specially shaped such that it can be trapped between layers of the composite adhesive strip (see e.g., alternatives of
In
More particularly, as otherwise described herein, a system and/or device 100 hereof may utilize one or multiple LED emitters 111c/111d of selected wavelengths and one or multiple photodiode sensors. However, In order to maximize coupling of the LED/sensor combination to the skin 1001 of a wearer 1000, a lens 121b comprised of optically clear, medical grade silicone may be molded onto or molded such that it may be later attached in covering relationship on the LED/sensor combination 111c/111d/112c. In many implementations, the lens 121b may be partially spherical or perhaps hemispherical in nature, though it need not be. Curvature of other shapes may be useful as well. Curvature reduces loss of skin contact when the device 100 may be moved, whether by wearer motion or otherwise. I.e., motion of the wearer 1000 or the device 100 relative to the wearer 1000 can result in a quasi-rolling contact of the lens on and in relation to the skin 1001. Better maintained skin contact means better data acquisition without interruption and/or with reduced noise.
Moreover, related to the function of maintaining contact is the light piping effect that may be achieved when LEDs and sensors, even of different heights are communicating without air gap interruption through the light pipe of the encapsulant material 121a. With no air gap from emitter to and through the light pipe 121a and with curved surface substantially constant contact with the skin, there is thus no air gap interruption in transmission into and through and reflected back on return from within the skin and back to the sensor via the same light pipe material 121a (transmission and reflection both referring to light travel). This reduces inefficiencies caused by light wave scattering at air gap interfaces (air gaps allow for light to bounce off the skin or other surface). I.e., encapsulation of the LEDs and the sensor; provides no air-gap and a light pipe effect to and the curved surface provides high quality low scattering transmission into the skin and reception of reflection from the skin and bone. The light pipe and curved lens surface maintain uninterrupted contact skin and lens reduces lost signals due skin reflection. The signal to noise ratio goes down and data acquisition goes up in quality.
Such a lens 121b may thus serve one or multiple purposes, including in some instances, inter alia: 1) providing a “light-pipe” effect to assure equal or otherwise high quality coupling of the different height LEDs and sensors, as well as substantially constant coupling to the skin to reduce motion artifact; 2) focusing of emitted light through the skin to the bone; and, 3) focusing of reflected light through the skin to the photodiode sensors.
As a further note, the radius of the lens may be designed to maximize 1) through 3). The height of the lens is designed to allow it to protrude above composite adhesive 113 of the device 100 and into the skin, but not deep enough to disturb the capillary bed which would also result in bad data. Moreover, the radius of curvature and the angles of LED lightwave emission are not necessarily highly controlled and need not be because the LEDs used to penetrate the skin, e.g., the red and infra-red LEDs; provide a very wide array of angles of emission, and thus a large number of reflected array of lightwaves will be focused back to the sensor by a large variety of curved surfaces. I.e., the curved surface is helpful for maintaining contact through movement (accidental or on purpose), and is less important to the angles of transmission through the skin and reflection back to the sensor. In other words, many different radii of curvature will be effective with very little difference in data/wave transmission and reflection; the wide angle emission of LED takes care of what might be a variety of radii. Rather, the curvature may have more limitation in the maintenance of contact due to movement of the device 100—e.g., flatter curvatures won't roll readily, and very small radii of curvature will not transmit or receive as much data.
In some implementations, a radii of curvature found useful have been between about 20 and 40 (both 20.34 mm and 39.94 mm radii of curvature have been found useful) for a device having LEDs and sensors in a compartment of about 12.6 mm by 6.6 mm. It may be noted further that LEDs may be on one side or another or on two opposing sides or perhaps at four or more substantially equi-distant points around a sensor and may provide desirable results.
Note further, pulse oximetry hereof may be with multiple light sources and/or sensors as may be one interpretation of the dispositions of
Furthermore, a combination of driven right leg and/or proxy driven right leg together with pulse oximetry can provide additional benefits. The right leg circuit, proxy right leg and/or driven right leg, whether for chest or forehead or other electrode placement, can remove common mode and power line noise that would/might otherwise be capacitively-coupled into the pulse oximetry sensor and reduce effectiveness thereof. A combination of driven right leg and/or proxy driven right leg and improved pulse oximetry with a lens as described in and for
The adhesive may thus be placed or disposed on the device 100, in some implementations substantially permanently, or with some replaceability. In some implementations, the device as shown in
Activation of the device after application to a patient/wearer may occur in a number of ways; in some, it may be pre-set that an affirmative activation interaction may not be necessary from the doctor or patient or like due to either an inertial and/or a pulse oximeter activation which may be substantially automatically activating, e.g., upon receiving sufficient minimum input (movement in case of inertial system or light reflection of blood flow for pulse oximetry); however, a button may be provided at an access 106 or in some other location adjacent the electronics to allow the patient to start or stop the device or otherwise mark an event if desired. In one exemplar implementation the device may be worn for a period such as two weeks for collection of data substantially continuously, or at intervals as may be preferred and established in or by the systems hereof.
After a monitoring period is over, a physician, technician, patient or other person may then remove the device from the patient body, in some instances remove the adhesive, in some instances with alcohol, and may establish a data communication connection for data transfer, e.g., by wireless communication or by insertion/connection of a USB or like data connector to download the data. The data may then be processed and/or interpreted and in many instances, interpreted immediately if desired. A power source on board may include a battery and this can then also be recharged between uses, in some implementations, fully recharged quickly as within about 24 hours, after which the device could then be considered ready for the next patient or next use.
Some alternative conductive adhesives may be used herewith.
The implementation of this particular example includes a composite adhesive 113a which itself may include some non-conductive portion(s) 113b and some one or more conductive portions 113c. The adhesive composite 113a may, as described for adhesive 113 above be double sided such that one side adheres to the patient while the other side would adhere to the underside 102 of the device 100 (see
As shown in
In some implementations, a further optional connective and/or insulative structure 113d may be implemented as shown in
Further alternatives related to the adhesive may be used. In some implementations, a composite adhesive strip may be used having properties to reduce one or more motion artifacts. Typical ECG attachment systems use a conductive gel located over the electrode. Here, however, a hydrogel adhesive may be used which is embedded in a continuous sheet of laminated adhesives that cover the selected regions or the entire footprint of the device. The fact that the hydrogel itself has strong adhesive properties coupled with the complete coverage of the device with adhesives may assure a strong bond between the device and the patient's skin. Contributing to motion artifact reduction may be an alternative vertical placement of the device on the sternum which results in reduced motion artifacts for one or more of ECG signals, photoplethysmography waveforms, and oxygen saturation signals.
In some implementations, composite adhesive improvements may include water-proof encapsulation of the hydrogel adhesive to prevent ohmic impedance reduction resulting in reduction of signal amplitude. This may also help prevent hydrocolloid adhesive degradation. In particular, as shown the non-limitative alternative exemplar in
Some alternative implementations hereof may include a driven right leg ECG circuit with one or more chest only electrodes (“Driven Chest Electrode”). In addition to the electrodes used to measure a single or multiple lead electrocardiogram signal, a device 100 may use an additional electrode, as for example the reference electrode 110 (see
A circuit or sub-circuit 200 using a transistor 201 as shown in
Further alternative descriptions of circuitry include that which is shown in
In many implementations, a system hereof may include other circuitry operative together with the ECG electrodes, which may thus be accompanied by other sensors to provide time concordant traces of: i) ECG p-, qrs-, and t-waves; ii) O2 Saturation, as measured by Pulse Oxymetry; and/or iii) xyz acceleration, to provide an index of physical activity. Such circuitry may be implemented to one or more of the following electrical specifications. The overall system might in some implementations include as much as two weeks (or more) of continuous run time; gathering data during such time. Some implementations may be adapted to provide as many or even greater than 1000 uses. Alternatives may include operability even after or during exposure to fluids or wetness; in some such examples being water resistant, or waterproof, or watertight, in some cases continuing to be fully operable when fully submerged (in low saline water). Other implementations may include fast data transfer, as for an example where using an HS USB for full data transfer in less than about 90 seconds. A rechargeable battery may typically be used.
A further alternative implementation may include an electronic “ground”: In a device hereof, mounted entirely on a flexible circuit board, the ground plane function may be provided by coaxial ground leads adjacent to the signal leads. The main contribution of this type of grounding system may be that it may allow the device the flexibility required to conform and adhere to the skin.
For electrocardiograph; EKG or ECG, some implementations may include greater than about 10 Meg Ohms input impedance; some implementations may operate with a 0.1-48 Hz bandwidth; and some with an approximate 256 Hz Sampling Rate; and may be implementing 12 Bit Resolution. For PPG and Pulse Oximeter, operation may be with 660 and 940 nm Wavelength; about 80-100 SpO2 Range; a 0.05-4.8 Hz Bandwidth; a 16 Hz Sampling Rate; and 12 bit resolution. For an accelerometer: a 3-Axis Measurement may be employed, and in some implementations using a ±2 G Range; with a 16 Hz Sampling Rate; and a 12 Bit Resolution.
For pulse oximetry, an option for PPG ambient light subtraction may be included. A method and circuitry for reducing errors in pulse oximetry caused by ambient light is described and a circuitry option shown in
The schematic shown in
If C1 is much larger than C2, nearly all the voltage will appear on C2, and the voltage on C2 will be equal to the noise-free signal (s). Otherwise, the voltage on C2 will be a linear combination of the previous C2 voltage (p) and the noise-free signal: (C2*s+C1*p)/(C1+C2). This has the effect of applying a first-order, low-pass, IIR discrete-time filter to the signal. If this filtering effect is not desired, the voltage on C2 may be discharged to zero before the signal is measured each cycle, so that the signal held on C2 is simply: (C2*s)/(C1+C2).
This circuit may be used with a trans-impedance amplifier in place of resistor R, a phototransistor in place of the photodiode, and FETs in place of the switches. The output may be followed by additional buffering, amplification, filtering and processing stages.
Some summary methodologies may now be understood with relation to
Several alternatives then present in
A similar such example, might be considered by the optional alternative flow path 312a which itself branches into parts 312b and 312c. Following flow path 312a, and then, in a first example path 312b, a skip of the transmit data operation 303 can be understood whereby analysis 304 might be achieved without substantial data transfer. This could explain on board analysis, whether as for example according to the threshold example above, or might in some instances include more detailed analysis depending upon how much intelligence is incorporated on/in the electronics 103. Another view is relative to how much transmission may be involved even if the transmission operation 303 is used; inasmuch as this could include at one level the transmission of data from the patient skin through the conductors 108, 109 and/or 110 through the traces 107 to the electronics 103 for analysis there. In other examples, of course, the transmission may include off-board downloading to other computing resources (e.g.,
Further alternatives primarily may involve data storage, both when and where, if used. As with intelligence, it may be that either some or no storage or memory may be made available in/by the electronics 103 on-board device 100. If some storage, whether a little or a lot, is made available on device 100, then, flow path 312a to and through path 312c may be used to achieve some storing of data 305. This may in many cases then, though not necessarily be before transmission or analysis (note, for some types of data multiple paths may be taken simultaneously, in parallel though perhaps not at the same time or serially (e.g., paths 312b and 312c need not be taken totally to the exclusion of the other), so that storage and transmission or storage and analysis may occur without necessarily requiring a completion of any particular operation before beginning or otherwise implementing another). Thus, after (or during) storage 305, flow path 315a may be followed for stored data which may then be transmitted, by path 315b to operation 303, and/or analyzed, by path 315c to operation 304. In such a storage example, which in many cases may also be an on-board storage example, data can be collected then stored in local memory and later off-loaded/transmitted to one or more robust computing resources (e.g.,
If little or no storage or memory is resident on device 100 (or in some examples even where there may be a large amount of resident memory available), then, relatively soon after collection, the data would need to or otherwise might desirably either or both be transmitted and then stored, see path 313a after operation 303, and/or transmitted and analyzed, paths 312 and 313. If path 313a is used, then, more typically, the data storage may be in/on computing resources (not shown in
A feature hereof may include an overall system including one or more devices 100 and computing resources (see
Alternative implementations hereof may thus include one or more hardware and software combinations for multiple alternative data source interpretations. As noted above, a device 100 hereof includes hardware that monitors one or more of various physiologic parameters, then generates and stores the associated data representative of the monitored parameters. Then, a system which includes hardware such as device 100 and/or the parts thereof, and software and computing resources (
For example, an electrocardiogram trace that reveals a ventricular arrhythmia during intense exercise may be interpreted differently than the same arrhythmia during a period of rest. Blood oxygen saturation levels that vary greatly with movement can indicate conditions that may be more serious than when at rest, inter alia. Many more combinations of the four physiologic parameters are possible, and the ability of software hereof to display and highlight possible problems will greatly aid the physician in diagnosis. Thus, a system as described hereof can provide beneficial data interpretation.
Some of the features which can assist toward this end may be subsumed within one or more of operations 303 and 304 of
The analysis/software package may be disposed to present the physician with results in a variety of formats. In some implementations, an overview of the test results may be presented, either together with or in lieu of more detailed results. In either case, a summary of detected anomalies and/or patient-triggered events may be provided, either as part of an overview and/or as part of the more detailed presentation. Selecting individual anomalies or patient-triggered events may provide desirable flexibility to allow a physician to view additional detail, including raw data from the ECG and/or from other sensors. The package may also allow data to be printed and saved with annotations in industry-standard EHR formats.
In one implementation, patient data may be analyzed with software having the one or more of the following specifications. Some alternative capabilities may include: 1. Data Acquisition; i.e., loading of data files from device; 2. Data Formatting; i.e., formatting raw data to industry standard file formats (whether, e.g., aECG (xml); DICOM; or SCP-ECG) (note, such data formatting may be a part of Acquisition, Storage or Analysis, or may have translation from one to another (e.g., data might be better stored in a compact format that may need translation or other un-packing to analyze)); 3. Data Storage (whether local, at a clinic/medical facility level or e.g., in the Cloud (optional and allows offline portable browser based presentation/analysis); 4. Analysis which inter alia, may include, e.g., noise filtering (High pass/Low pass digital filtering); and/or QRS (Beat) detection (in some cases, may include Continuous Wave Transform (CWT) for speed and accuracy); and/or 5. Data/Results Presentation, whether including one or more graphical user interface(s) (GUIs) perhaps more particularly with an overall Summary and/or General Statistics and/or Anomaly Summary of Patient triggered event(s); presentation of additional levels of detail whether of Strip view(s) of anomaly data by incident (previous, next) Blood Oxygen saturation, stress correlation or the like; and/or allowing care provider bookmarking/annotations/notes by incident and/or Print capability.
Further, on alternative combinations of hardware with proprietary software packages: I) One on-device software package may be adapted to store the measurements from the data signals acquired from one or more of EKG/ECG (whether right leg and/or p-, qrs- and/or t-waves), or O2 saturation, or xyz acceleration, in a time concordant manner, so that a physician may access a temporal history of the measurements (say, in some examples, over a 1-2 week interval), which would provide useful information on what the patient's activity level was prior to, during, and after the occurrence of a cardiac event. ii) an alternative to alternately manage the real-time transmission of the real-time measured parameters to a nearby station or relay. And/or; iii) an off-device ECG analysis software aimed at recognizing arrhythmias.
The software mentioned above may be industry understood software provided by a 3rd party, or specially adapted for the data developed and transmitted by and/or received from a wearable device 100 hereof. Thorough testing using standard (MIT-BIH/AHA/NST) arrhythmia databases, FDA 510(k) approvals preferred. Such software may be adapted to allow one or more of automated ECG analysis and interpretation by providing callable functions for ECG signal processing, QRS detection and measurement, QRS feature extraction, classification of normal and ventricular ectopic beats, heart rate measurement, measurement of PR and QT intervals, and rhythm interpretation.
In many implementations, the software may be adapted to provide and/or may be made capable of supplying one or more of the following measurements:
Table 1:
Table 2A:
This first group of 8 given above are arrhythmia types that may be recognizable even if there is no discernible P wave. They are the ones typically recognized by existing products in the outpatient monitoring market that we propose to address.
A second set or group of arrhythmias; below, may require a discernible and measurable P wave. Some implementations hereof may be adapted to be able to detect and recognize them, as device 100 may be able as described above to detect P waves, depending of course, and for example, on whether the strength of the P wave which may be affected by device 100 placement or patient physiology.
Table 2B:
Further in alternative software implementations; some sample screenshots are shown in
Another alternative is shown in
As introduced,
As introduced,
As mentioned above, in one aspect of the developments hereof, ECG signals collected in time concordance with pulse oximetry signals may be used to reduce the noise in the pulse oximetry signals and to permit the calculation of values for oxygen saturation, particularly in circumstances where sensors pulse oximetry data are placed on noise-prone locations of a patient, such as the chest. In some embodiments, this aspect may be implemented by the following steps: (a) measuring an electrocardiogram signal over multiple heart beats; (b) measuring one or more pulse oximetry signals over multiple heart beats such that the electrocardiogram signal and the one or more pulse oximetry signals are in time concordance over one or more heart beats; (c) comparing a portion of the electrocardiogram signal and the one or more pulse oximetry signals in time concordance over one or more heart beats to determine a constant component and a primary periodic component of each of the one or more pulse oximetry signals; and (d) determining oxygen saturation from the constant components and primary periodic components of the one or more pulse oximetry signals. Measurement of the ECG signals and pulse oximetry signals may be implemented by embodiments of devices hereof. In particular, pulse oximetry signals may be a reflective infrared signal and a reflective red light signal collected by a photodetector in a device hereof. Intervals of pulse oximetry signals corresponding to heart beats may be determined by comparing such signals to the time concordant ECG signals. For example (not intended to be limiting), successive R-wave peaks of a time concordant ECG signal may be used to identify such intervals, although other features of the ECG signal may be used as well. Once such intervals are identified, values at corresponding times within the intervals may be averaged to reduce signal noise and to obtain more reliable values for the constant components (sometimes referred to as the “DC components”) and the main periodic components (sometimes referred to as the “AC components”) of the pulse oximetry signals, e.g. Warner et al, Anesthesiology, 108: 950-958 (2008). The number of signal values recorded in an interval depends on the signal sampling rate of the detectors and processing electronics employed. Also, as the intervals may vary in duration, the averaging may be applied to a subset of values in the intervals. As described below, oxygen saturation values may be computed from such DC and AC components using conventional algorithms. The number of heart beats or intervals over which such averages may be computed may vary widely, as noted below. In some embodiments, signals from one or more heart beats or intervals may be analyzed; in other embodiments, signals from a plurality of heart beats or intervals may be analyzed; and in some embodiments, such plurality may be in the range of from 2 to 25, or in the range of from 5 to 20, or in the range of from 10 to 20.
In further alternative implementations, a linear regression algorithm for Oxygen Saturation may be used. As such, the patient's ECG signal may be used to determine when heart beats occur. The beat locations allow correlated time averaging of each of the two photoplethysmogram signals. A linear regression of the ensemble averages may then be used to determine the linear gain factor between the two signals. This gain factor can be used to determine the patient oxygen saturation.
ECG data may be recorded in time-concordance with two or more photoplethysmographs of different light wavelengths. The heart beats are detected in the ECG signal. These heart beats allow for definition of a ‘frame’ of photoplethysmogram data for the time between two adjacent heart beats. Two or more of these frames can then be averaged together at each point in time to create an average frame for the time interval. Because the photoplethysmogram is correlated with the heartbeat, the photoplethysmograph signal is reinforced by this averaging. However, any motion artifact or other noise source that is uncorrelated in time with the heartbeat is diminished. Thus, the signal-to-noise ratio of the average frame is typically higher than that of the individual frames.
Having constructed an average frame for at least two photoplethysmographs of different light wavelengths, linear regression can then be used to estimate the gain between the two average frame signals. This gain value may be used to estimate blood oxygen saturation information or other components present in the blood such as hemoglobin, carbon dioxide or others. The process may be repeated for additional light wavelengths in order to do so.
An exemplar/alternative method hereof may include determining the gain between particular signals, as between the red and IR frame signals, if/when such may be used. These may be found by averaging the two frames together first. This may result in a signal with reduced noise. The gain is found by performing linear regression of the red versus combined and IR versus combined and then finding the ratio of these two results.
Another method involves selecting a possible gain value, multiplying the average frame signal by it, and determining the residual error with respect to an average frame of a different wavelength. This process may be repeated for a number of potential gain values. While simple linear regression finds the global minimum gain value, this method allows for finding local minima. Thus, if it is likely that the global minimum represents correlation caused by motion artifact, venous blood movement or another noise source, it may be ignored, and a local minimum may be selected instead.
As mentioned above, patient wearable devices hereof for implementing the above aspects may be particularly useful for monitoring oxygen saturation in noisy regions for such measurements, for example, where there is significant local skin movement, such as the chest location.
One embodiment of the above aspect hereof is illustrated in
In addition to the above embodiment for comparing ECG signals with pulse oximetry signals, a range of other embodiments for such comparing is within the comprehension of those of ordinary skill in the art. For example, in order to find peaks of the AC component of pulse oximetry signals in the presence of noise, features of the time concordant ECG signal that are located at characteristic times preceding and succeeding the pulse oximetry maximum and/or minimum values may be used to reliably determine the pulse oximetry peak and minimum values when averaged over a plurality of heart beats (without the need to average all values of the pulse oximetry signal over the heart beats). For example, if, within an interval, the R wave peak of an ECG signal characteristically preceded a pulse oximetry signal maximum by x milliseconds and trailed a pulse oximetry signal minimum by y milliseconds, then the essential information about the AC component of the pulse oximetry signal may be obtained by repeated measurements of just two values of pulse oximetry signals.
In some embodiments, values for IR or red reflection measured by the photodiode may be used to estimate depth and/or rate of respiration. In
Moreover, moving from an appreciation of a derivation of a respiration waveform from ECG R-S amplitude and/or R-R intervals, it has been found that a PPG and/or pulse oximeter as described herein can be used to relatively directly estimate a respiration waveform. As the chest expands and contracts during breathing, the motion hereof shows up as a wandering baseline artifact on the PPG signals. The respiration signal may be isolated by filtering out the PPG data to focus on the breathing/respiration signal. This may be particularly so with a chest-mounted PPG.
In addition, a chest mounted accelerometer may also or alternatively be used to measure the respiration waveform, especially when the user is lying on his/her back. As the chest expands and contracts, the chest accelerates up and down (or transversely, or otherwise depending upon orientation), which can be measured by the accelerometer.
Either of these, PPG and/or accelerometer, devices and/or methods may be used discretely or in combination with each other and/or with the above-described ECG-based respiration estimation technique. Using multiple methods may improve accuracy when compared to estimates based on a single method. Respiration rate and depth may then be estimated from the respiration signal using time-domain and/or frequency domain methods.
In some implementations, heart beat timing (e.g., from ECG) and PPG signals can be used to determine pulse transit time; i.e., the time for the pressure wave to travel from the heart to other locations in the body. Measurements of pulse transit time may then be used to determine or estimate blood pressure. Note, the heartbeat timing, ECG and/or PPG signals may be generated by conventional or other to-be-developed methods, systems or devices, or may be developed by wearable devices such as those otherwise described herein. I.e., the algorithms hereof may be separately usable, as well as being usable in the wearable cardiac device.
As disclosed herein elsewhere, the PPG signals of several heart beats may be averaged by correlating each with a respective heartbeat. The result is a PPG frame where the heart rate-correlated PPG signal is reinforced while uncorrelated noise is diminished. Moreover, because the PPG frame is already correlated to the timing of the heartbeat, pulse transit time may be estimated by determining the location of either the peak or minimum with respect to either the beginning or end of the frame itself. This may be done either by finding the minimum and/or maximum sample(s), or by interpolating the signal to find points between measured samples. For example, interpolation may be done with a quadratic fit, a cubic spline, digital filtering, or many other methods.
The pulse transit time may also be estimated by correlating the PPG frame with a sample signal. By shifting the two signals with respect to each other, the time shift resulting in the maximum correlation may be determined. If the sample signal is an approximation of the expected PPG frame, then the time shift with maximum correlation may be used to determine the pulse transit time.
An exemplar methodology or algorithm herefor is described here and shown in the drawing
Optionally, but, typically, a PPG signal quality estimate may also be performed. An example of this is shown as method part 710b in
As shown in
Once the average frame 715 has been produced for a given instant in time, the pulse transit time 716 may be determined by finding the shift in the frame signal with respect to the heartbeat. This may be done simply by finding the sample index 717 where the signal is at a minimum or maximum and comparing it with the frame boundary (heartbeat timing) to determine the pulse transit time. For a more precise result, the signal may be interpolated 718 using a spline or polynomial fit around the minimum or maximum values, allowing the minimum or maximum to be determined with greater precision than the sample rate. Finally, the frame may be compared 719 to a reference frame template, where the average frame is shifted with respect to the template. The shift with the highest correlation between the average frame and the template indicates the transit time 716. This reference template may be a predetermined signal, or it may be allowed to adapt by using a long-term frame average with a known transit time.
Note, such methodologies may be used with PPG and heartbeat timing information obtained from a variety of sources, including but not limited to conventional and/or to-be-developed technologies; or, may be obtained one or the other alone or together and/or together with quality signal (PPG variance, estimated PPG signal-to-noise ratio, PPG signal saturation, patient motion accelerometer or gyroscope data, an ECG or impedance measurement noise estimate, or other information about the PPG signal quality) obtained from a wearable device and/or system as described further hereinbelow.
Some further alternatives may include data transmission and/or interpretation by local medical facilities, whether physician or doctor offices or e.g., ICU/CCU (Intensive Care/Coronary Care Units). Accordingly, a device 100 hereof that will measure one or more of a variety of physiologic signals, possibly including electrocardiogram, photoplethysmogram, pulse oximetry and/or patient acceleration signals will be placed on the patient's chest and held with an adhesive as described herein. The device transmits the physiologic signals wirelessly or by wire (e.g., USB) to a nearby base station for interpretation and further transmission, if desired. The wireless transmission may use Bluetooth, Wi-Fi, Infrared, RFID (Radio Frequency IDentification) or another wireless protocol. The device may be powered by wireless induction, battery, or a combination of the two. The device 100 monitors physiological signals and/or collects data representative thereof. The collected data may then be transmitted wirelessly or by wire connection, in real time, to the nearby base station. The device may be wirelessly powered by the base station or by battery, removing the need for wires between the patient and the station.
Relatedly and/or alternatively, patients or wearers may be monitored wirelessly in a hospital, including an ICU (Intensive Care Unit) or other facility. As such, an ECG signal may be measured on a patient using a small, wireless patch device hereof. The signal is then digitized and transmitted wirelessly to a receiver. The receiver converts the signal back to analog, such that it approximates the original ECG signal in amplitude. This output is then presented to an existing hospital ECG monitor through the standard electrode leads. This allows the patient to be monitored using existing hospital infrastructure without any lead wires necessarily connecting the patient to the monitor. Patient chest impedance may be measured as well, allowing the reconstructed signal to approximate the ECG signal not only in amplitude, but in output impedance as well. This can be used to detect a disconnected patch. The output impedance may be continuously variable, or it may have discrete values that may be selected (e.g. one low value for a connected device and one high value to signify the patch has come loose). The impedance may also be used to signify problems with the wireless transmission.
Other alternative implementations may include coupling one or multiple sensors mounted to the forehead of an infant. Initially, a method of obtaining oxygen saturation data by mounting a device in the forehead of an infant might be used as introduced. However, an expansion or alternative may include coupling oxygen saturation sensors with relative position and temperature sensors on the same forehead-mounted device. The combined data can be utilized to ascertain if an infant is in any danger of suffocation due to a face-down position.
Thus, some of the alternative combinations hereof may include one or more of: 1) medical grade adhesives (from many possible sources) selected for their ability to maintain in intimate contact with the skin without damaging it, for several days (up to, say 10 days or two weeks in some examples), as well as operability with different types of sensors; 2) conductive electrodes or photo-sensitive detectors able to supply electrical signals from the skin or from the photo-response of cutaneous or subcutaneous tissues to photo-excitation; 3) amplifiers, microprocessors and memories, capable of treating these signals and storing them; 4) power supply for the electronics hereof with stored or with wirelessly accessible re-chargeability; 5) flex circuits capable of tying the above elements together within a flexible strip capable of conforming to a cutaneous region of interest.
Examples of physiological parameters that may be subject to monitoring, recordation/collection and/or analyzing may include one or more of: electrocardiograms, photo responses of photo-excited tissues for e.g., oxygen saturation of blood; pulse rates and associated fluctuations; indications of physical activity/acceleration. One or more of these may be used in monitoring ambulatory cardiac outpatients over several days and nights, which could thereby provide for recording, for post-test analysis, several days' worth of continuous ECG signals together with simultaneous recording of O2 saturation and an index of physical exertion. Similarly, one or more of these may be used in monitoring ambulatory pulmonary outpatients over several days and nights for recording, for post-test analysis, O2 saturation together with simultaneous recording of an index of physical activity. Alternatively and/or additionally, one or more of these could be used for monitoring in-patients or other patients of interest, as for example neonates, wirelessly (or in some cases wired), whether in clinics, emergency rooms, or ICUs, in some instances detecting the parameters of EKG, O2 and/or physical exertion, but instead of storing them would transmit them wirelessly to either a bedside monitor or a central station monitor, thus freeing the patient from attachment to physical wires. In particular, devices hereof may be adhered to the forehead of a neonate for monitoring respiration and oxygen saturation. In further alternatives, devices hereof may be used to monitor respiration and ECG of patients suffering from sleep apnea.
An exemplary computer system or computing resources which may be used herewith will now be described, though it should be noted that many alternatives in computing systems and resources may be available and operable within the reasonably foreseeable scope hereof so that the following is intended in no way to be limiting of the myriad possible computational alternatives properly intended within both the spirit and scope hereof.
Some of the implementations of the present developments include various steps. A variety of these steps may be performed by hardware components or may be embodied in machine-executable instructions, which may be used to cause a general-purpose or special-purpose processor programmed with the instructions to perform the steps. Alternatively, the steps may be performed by a combination of hardware, software, and/or firmware. As such,
Processor(s) 402 can be any known processor, such as, but not limited to, an Intel® Itanium® or Itanium 2® processor(s), or AMD® Opteron® or Athlon MP® processor(s), or Motorola® lines of processors. Communication port(s) 403 can be any of an RS-232 port for use with a modem based dialup connection, a 10/100 Ethernet port, a Universal Serial Bus (USB) port, or a Gigabit port using copper or fiber. Communication port(s) 403 may be chosen depending on a network such a Local Area Network (LAN), Wide Area Network (WAN), or any network to which the computer system 400 connects or may be adapted to connect.
Main memory 404 can be Random Access Memory (RAM), or any other dynamic storage device(s) commonly known in the art. Read only memory 406 can be any static storage device(s) such as Programmable Read Only Memory (PROM) chips for storing static information such as instructions for processor 402.
Mass storage 407 can be used to store information and instructions. For example, hard disks such as the Adaptec® family of SCSI drives, an optical disc, an array of disks such as RAID, such as the Adaptec family of RAID drives, or any other mass storage devices may be used.
Bus 401 communicatively couples processor(s) 402 with the other memory, storage and communication blocks. Bus 401 can be a PCI/PCI-X or SCSI based system bus depending on the storage devices used.
Removable storage media 405 can be any kind of external hard-drives, floppy drives, IOMEGA® Zip Drives, Compact Disc-Read Only Memory (CD-ROM), Compact Disc-Re-Writable (CD-RW), Digital Video Dis-Read Only Memory (DVD-ROM).
The components described above are meant to exemplify some types of possibilities. In no way should the aforementioned examples limit the scope of the invention, as they are only exemplary embodiments.
Embodiments of the present invention relate to devices, systems, methods, media, and arrangements for monitoring and processing cardiac parameters and data, inter alia. While detailed descriptions of one or more embodiments of the invention have been given above, various alternatives, modifications, and equivalents will be apparent to those skilled in the art without varying from the spirit of the invention. Therefore, the above description should not be taken as limiting the scope of the invention, which is defined by the appended claims.
| Number | Name | Date | Kind |
|---|---|---|---|
| 3769669 | Peacock et al. | Nov 1973 | A |
| 3830970 | Hurley et al. | Aug 1974 | A |
| 3911906 | Reinhold, Jr. | Oct 1975 | A |
| 4141366 | Cross, Jr. et al. | Feb 1979 | A |
| 4164215 | Finlayson et al. | Aug 1979 | A |
| 4221223 | Linden | Sep 1980 | A |
| 4224948 | Cramer | Sep 1980 | A |
| 4230127 | Larson | Oct 1980 | A |
| 4295472 | Adams | Oct 1981 | A |
| 4360030 | Citron et al. | Nov 1982 | A |
| 4412546 | Barthels | Nov 1983 | A |
| 4494550 | Blazek et al. | Jan 1985 | A |
| 4580339 | Ioffe | Apr 1986 | A |
| 4583190 | Salb | Apr 1986 | A |
| 4583549 | Manoli | Apr 1986 | A |
| 4674511 | Cartmell | Jun 1987 | A |
| 4803992 | Lemelson | Feb 1989 | A |
| 4859057 | Taylor et al. | Aug 1989 | A |
| 4869254 | Stone et al. | Sep 1989 | A |
| 4880304 | Jaeb et al. | Nov 1989 | A |
| 4890622 | Ferrari | Jan 1990 | A |
| 4902886 | Smisko | Feb 1990 | A |
| 4934372 | Corenman et al. | Jun 1990 | A |
| 4938228 | Righter et al. | Jul 1990 | A |
| 4967264 | Parulski et al. | Oct 1990 | A |
| 5025791 | Niwa | Jun 1991 | A |
| 5184620 | Cudahy et al. | Feb 1993 | A |
| 5203329 | Takatani et al. | Apr 1993 | A |
| 5215087 | Anderson | Jun 1993 | A |
| 5224486 | Lerman et al. | Jul 1993 | A |
| 5261401 | Baker et al. | Nov 1993 | A |
| 5265579 | Ferrari | Nov 1993 | A |
| 5307818 | Segalowitz | May 1994 | A |
| 5372125 | Lyons | Dec 1994 | A |
| 5419321 | Evans | May 1995 | A |
| 5427093 | Ogawa et al. | Jun 1995 | A |
| 5448991 | Polson | Sep 1995 | A |
| 5465715 | Lyons | Nov 1995 | A |
| 5465727 | Reinhold | Nov 1995 | A |
| 5511553 | Segalowitz | Apr 1996 | A |
| 5549116 | Mauer | Aug 1996 | A |
| 5632272 | Diab et al. | May 1997 | A |
| 5673692 | Schulze et al. | Oct 1997 | A |
| 5730143 | Schwarzberg | Mar 1998 | A |
| 5779631 | Chance | Jul 1998 | A |
| 5817008 | Rafert et al. | Oct 1998 | A |
| 5912703 | Tamayama | Jun 1999 | A |
| 5931791 | Saltzstein et al. | Aug 1999 | A |
| 5938597 | Stratbucker | Aug 1999 | A |
| 5971930 | Elghazzawi | Oct 1999 | A |
| 6032060 | Carim et al. | Feb 2000 | A |
| 6041247 | Weckstrom | Mar 2000 | A |
| 6088607 | Diab et al. | Jul 2000 | A |
| 6122535 | Kaestle et al. | Sep 2000 | A |
| 6134460 | Chance | Oct 2000 | A |
| 6263222 | Diab et al. | Jul 2001 | B1 |
| 6327487 | Stratbucker | Dec 2001 | B1 |
| 6385473 | Haines | May 2002 | B1 |
| 6453186 | Lovejoy et al. | Sep 2002 | B1 |
| 6525386 | Mills | Feb 2003 | B1 |
| 6526300 | Kiani et al. | Feb 2003 | B1 |
| 6569095 | Eggers | May 2003 | B2 |
| 6647287 | Peel et al. | Nov 2003 | B1 |
| 6662033 | Casciani et al. | Dec 2003 | B2 |
| 6665385 | Rogers et al. | Dec 2003 | B2 |
| 6694177 | Eggers et al. | Feb 2004 | B2 |
| 6699194 | Diab et al. | Mar 2004 | B1 |
| 6725074 | Kaestle | Apr 2004 | B1 |
| 6745061 | Hicks et al. | Jun 2004 | B1 |
| 6830711 | Mills et al. | Jun 2004 | B2 |
| 6801137 | Eggers | Oct 2004 | B2 |
| 6934570 | Kiani et al. | Aug 2005 | B2 |
| 6940403 | Kail, IV | Sep 2005 | B2 |
| 7018338 | Vetter et al. | Mar 2006 | B2 |
| 7027858 | Cao et al. | Apr 2006 | B2 |
| 7067893 | Mills et al. | Jun 2006 | B2 |
| 7099715 | Korzinov et al. | Aug 2006 | B2 |
| 7130396 | Rogers et al. | Oct 2006 | B2 |
| 7194300 | Korzinov | Mar 2007 | B2 |
| 7212850 | Prystowsky | May 2007 | B2 |
| 7215984 | Diab et al. | May 2007 | B2 |
| 7257438 | Kinast | Aug 2007 | B2 |
| 7332784 | Mills et al. | Feb 2008 | B2 |
| 7341559 | Schulz et al. | Mar 2008 | B2 |
| 7412282 | Houben | Aug 2008 | B2 |
| 7502643 | Farringdon et al. | Mar 2009 | B2 |
| 7553166 | Gobron | Jun 2009 | B2 |
| 7587237 | Korzinov et al. | Sep 2009 | B2 |
| 7668588 | Kovacs | Feb 2010 | B2 |
| 7729753 | Kremliovsky et al. | Jun 2010 | B2 |
| 7831301 | Webb et al. | Nov 2010 | B2 |
| 7881765 | Mertz et al. | Feb 2011 | B2 |
| D634431 | Severe et al. | Mar 2011 | S |
| 7904133 | Gehman et al. | Mar 2011 | B2 |
| 7907996 | Prystowsky et al. | Mar 2011 | B2 |
| 7941207 | Korzinov | May 2011 | B2 |
| 7962202 | Bhunia | Jun 2011 | B2 |
| 7988638 | Novae | Aug 2011 | B2 |
| 8116841 | Bly et al. | Feb 2012 | B2 |
| 8145287 | Diab et al. | Mar 2012 | B2 |
| 8150502 | Kumar et al. | Apr 2012 | B2 |
| 8160682 | Kumar et al. | Apr 2012 | B2 |
| D659836 | Bensch et al. | May 2012 | S |
| 8172761 | Rulkov et al. | May 2012 | B1 |
| 8200319 | Pu et al. | Jun 2012 | B2 |
| 8200320 | Kovacs | Jun 2012 | B2 |
| 8203704 | Merritt et al. | Jun 2012 | B2 |
| 8219198 | Gollasch et al. | Jul 2012 | B2 |
| 8249686 | Libbus et al. | Aug 2012 | B2 |
| 8271072 | Houben et al. | Sep 2012 | B2 |
| RE43767 | Eggers et al. | Oct 2012 | E |
| 8285356 | Bly et al. | Oct 2012 | B2 |
| 8290129 | Rogers et al. | Oct 2012 | B2 |
| 8290574 | Field et al. | Oct 2012 | B2 |
| 8301236 | Baumann et al. | Oct 2012 | B2 |
| 8374686 | Ghanem | Feb 2013 | B2 |
| 8428682 | Rood et al. | Apr 2013 | B1 |
| 8452364 | Hannula et al. | May 2013 | B2 |
| 8460189 | Libbus et al. | Jun 2013 | B2 |
| 8473039 | Michelson et al. | Jun 2013 | B2 |
| 8473047 | Chakravarthy et al. | Jun 2013 | B2 |
| 8538503 | Kumar et al. | Sep 2013 | B2 |
| 8554311 | Warmer et al. | Oct 2013 | B2 |
| 8560046 | Kumar et al. | Oct 2013 | B2 |
| 8577431 | Lamego et al. | Nov 2013 | B2 |
| 8585605 | Sola I Caros et al. | Nov 2013 | B2 |
| 8591430 | Amurthur et al. | Nov 2013 | B2 |
| D701964 | Yoneta et al. | Apr 2014 | S |
| 8688190 | Libbus et al. | Apr 2014 | B2 |
| 8718752 | Libbus et al. | May 2014 | B2 |
| 8731649 | Lisogurski | May 2014 | B2 |
| 8743258 | Park et al. | Jun 2014 | B2 |
| 8821397 | Al-Ali et al. | Sep 2014 | B2 |
| 8989830 | LeBoeuf et al. | Mar 2015 | B2 |
| D738757 | Cross et al. | Sep 2015 | S |
| D744109 | Yoneta et al. | Nov 2015 | S |
| D744110 | Kubo et al. | Nov 2015 | S |
| 9186112 | Bechtel et al. | Nov 2015 | B2 |
| 9241643 | Lisogurski | Jan 2016 | B2 |
| 9277864 | Yang et al. | Mar 2016 | B2 |
| 9289175 | LeBoeuf et al. | Mar 2016 | B2 |
| D760903 | Lin et al. | Jul 2016 | S |
| 9392946 | Sarantos | Jul 2016 | B1 |
| 9398870 | Bechtel et al. | Jul 2016 | B2 |
| 9506802 | Chu et al. | Nov 2016 | B2 |
| D787066 | Kim et al. | May 2017 | S |
| 9636057 | Scheuing et al. | May 2017 | B2 |
| 9642565 | Gonopolskiy et al. | May 2017 | B2 |
| 9664556 | Chu et al. | May 2017 | B2 |
| 9696199 | Chu et al. | Jul 2017 | B2 |
| 9717425 | Kiani et al. | Aug 2017 | B2 |
| 9752925 | Chu et al. | Sep 2017 | B2 |
| D800313 | Chang | Oct 2017 | S |
| 9775548 | Sarantos et al. | Oct 2017 | B2 |
| 9782132 | Golda et al. | Oct 2017 | B2 |
| 9801547 | Yuen et al. | Oct 2017 | B2 |
| D810944 | Goolkasian | Feb 2018 | S |
| 9888872 | Bechtel et al. | Feb 2018 | B2 |
| D812229 | Al-Siddiq | Mar 2018 | S |
| 10045722 | Kintz et al. | Aug 2018 | B2 |
| 10080527 | Golda et al. | Sep 2018 | B2 |
| 10088356 | Chu et al. | Oct 2018 | B2 |
| 10244949 | Moyer et al. | Apr 2019 | B2 |
| D850626 | Gardner et al. | Jun 2019 | S |
| D851253 | Goolkasian | Jun 2019 | S |
| 10413251 | Golda et al. | Sep 2019 | B2 |
| D868974 | Albert et al. | Dec 2019 | S |
| D868977 | Vardi | Dec 2019 | S |
| D880703 | Emery et al. | Apr 2020 | S |
| 10610159 | Eletr et al. | Apr 2020 | B2 |
| 10824391 | Savolainen et al. | Nov 2020 | B2 |
| 10863947 | Golda et al. | Dec 2020 | B2 |
| 10959678 | Golda et al. | Mar 2021 | B2 |
| 10980486 | Van Zandt Moyer et al. | Apr 2021 | B2 |
| D931467 | Golda et al. | Sep 2021 | S |
| 11185291 | Eletr et al. | Nov 2021 | B2 |
| 20020026127 | Balbierz et al. | Feb 2002 | A1 |
| 20020038082 | Chin | Mar 2002 | A1 |
| 20020072685 | Rymut et al. | Jun 2002 | A1 |
| 20020180605 | Ozguz et al. | Dec 2002 | A1 |
| 20030055478 | Lyster | Mar 2003 | A1 |
| 20030065269 | Vetter et al. | Apr 2003 | A1 |
| 20030073916 | Yonce | Apr 2003 | A1 |
| 20030139654 | Kim et al. | Jul 2003 | A1 |
| 20030176795 | Harris et al. | Sep 2003 | A1 |
| 20030225322 | Uchiyama et al. | Dec 2003 | A1 |
| 20030225323 | Kiani et al. | Dec 2003 | A1 |
| 20040010201 | Korzinov et al. | Jan 2004 | A1 |
| 20040015091 | Greenwald et al. | Jan 2004 | A1 |
| 20040039419 | Stickney et al. | Feb 2004 | A1 |
| 20040039420 | Jayne et al. | Feb 2004 | A1 |
| 20040042581 | Okerlund | Mar 2004 | A1 |
| 20040054273 | Finneran et al. | Mar 2004 | A1 |
| 20040082842 | Lumba et al. | Apr 2004 | A1 |
| 20040082862 | Chance | Apr 2004 | A1 |
| 20040146149 | Rogers et al. | Jul 2004 | A1 |
| 20040260189 | Eggers et al. | Dec 2004 | A1 |
| 20050096557 | Vosburgh | May 2005 | A1 |
| 20050187446 | Nordstrom | Aug 2005 | A1 |
| 20050197549 | Baker, Jr. | Sep 2005 | A1 |
| 20050261559 | Mumford | Nov 2005 | A1 |
| 20050277841 | Shennib | Dec 2005 | A1 |
| 20050288726 | Gollasch | Dec 2005 | A1 |
| 20060056487 | Kuroda et al. | Mar 2006 | A1 |
| 20060167515 | Stickney et al. | Jul 2006 | A1 |
| 20060170649 | Kosugi et al. | Aug 2006 | A1 |
| 20060224072 | Shennib | Oct 2006 | A1 |
| 20070032719 | Menon et al. | Feb 2007 | A1 |
| 20070070800 | Virag et al. | Mar 2007 | A1 |
| 20070093705 | Shin et al. | Apr 2007 | A1 |
| 20070103296 | Paessel et al. | May 2007 | A1 |
| 20070106136 | Sterling et al. | May 2007 | A1 |
| 20070129642 | Korzinov | Jun 2007 | A1 |
| 20070130657 | Rogers et al. | Jun 2007 | A1 |
| 20070142715 | Banet et al. | Jun 2007 | A1 |
| 20070156054 | Korzinov et al. | Jul 2007 | A1 |
| 20070167850 | Russell et al. | Jul 2007 | A1 |
| 20070191723 | Prystowsky et al. | Aug 2007 | A1 |
| 20070191728 | Shennib | Aug 2007 | A1 |
| 20070206655 | Haslett et al. | Sep 2007 | A1 |
| 20070208542 | Vock et al. | Sep 2007 | A1 |
| 20070255156 | Mertz et al. | Nov 2007 | A1 |
| 20070255184 | Shennib | Nov 2007 | A1 |
| 20070282212 | Sierra et al. | Dec 2007 | A1 |
| 20070293776 | Korzinov et al. | Dec 2007 | A1 |
| 20080061846 | Kase et al. | Mar 2008 | A1 |
| 20080091090 | Guillory et al. | Apr 2008 | A1 |
| 20080101064 | Draganov | May 2008 | A1 |
| 20080139953 | Baker et al. | Jun 2008 | A1 |
| 20080288026 | Cross | Nov 2008 | A1 |
| 20080300641 | Brunekreeft et al. | Dec 2008 | A1 |
| 20090054742 | Kaminska | Feb 2009 | A1 |
| 20090076340 | Libbus et al. | Mar 2009 | A1 |
| 20090076341 | James et al. | Mar 2009 | A1 |
| 20090076342 | Amurthur et al. | Mar 2009 | A1 |
| 20090076344 | Libbus et al. | Mar 2009 | A1 |
| 20090076345 | Manicka et al. | Mar 2009 | A1 |
| 20090076346 | James et al. | Mar 2009 | A1 |
| 20090076349 | Libbus et al. | Mar 2009 | A1 |
| 20090076350 | Bly et al. | Mar 2009 | A1 |
| 20090076363 | Bly et al. | Mar 2009 | A1 |
| 20090076364 | Libbus et al. | Mar 2009 | A1 |
| 20090076397 | Libbus et al. | Mar 2009 | A1 |
| 20090076405 | Amurthur et al. | Mar 2009 | A1 |
| 20090076410 | Libbus et al. | Mar 2009 | A1 |
| 20090076559 | Libbus et al. | Mar 2009 | A1 |
| 20090105602 | Gehman et al. | Apr 2009 | A1 |
| 20090171177 | Hannula et al. | Jul 2009 | A1 |
| 20090234410 | Libbus et al. | Sep 2009 | A1 |
| 20090290279 | Rodgriguez et al. | Nov 2009 | A1 |
| 20090306536 | Ranganathan et al. | Dec 2009 | A1 |
| 20100004518 | Vo et al. | Jan 2010 | A1 |
| 20100026995 | Merritt et al. | Feb 2010 | A1 |
| 20100030039 | Lamego | Feb 2010 | A1 |
| 20100054138 | Gips et al. | Mar 2010 | A1 |
| 20100134241 | Gips et al. | Jun 2010 | A1 |
| 20100160794 | Banet et al. | Jun 2010 | A1 |
| 20100179391 | Quintanar et al. | Jul 2010 | A1 |
| 20100191509 | Li et al. | Jul 2010 | A1 |
| 20100198044 | Gehman et al. | Aug 2010 | A1 |
| 20100204586 | Pu et al. | Aug 2010 | A1 |
| 20100204599 | Pu et al. | Aug 2010 | A1 |
| 20100249541 | Geva et al. | Sep 2010 | A1 |
| 20100262430 | Gips et al. | Oct 2010 | A1 |
| 20100268103 | Mcnamara et al. | Oct 2010 | A1 |
| 20100324387 | Moon et al. | Oct 2010 | A1 |
| 20100286495 | McGonigle et al. | Nov 2010 | A1 |
| 20100286532 | Farringdon et al. | Nov 2010 | A1 |
| 20100298655 | McCombie | Nov 2010 | A1 |
| 20100298656 | McCombie | Nov 2010 | A1 |
| 20100312188 | Robertson | Dec 2010 | A1 |
| 20100317937 | Kuhn et al. | Dec 2010 | A1 |
| 20100317942 | Cinbis et al. | Dec 2010 | A1 |
| 20100317947 | Cinbis et al. | Dec 2010 | A1 |
| 20100317958 | Beck et al. | Dec 2010 | A1 |
| 20100318146 | Cinbis et al. | Dec 2010 | A1 |
| 20100324389 | Moon et al. | Dec 2010 | A1 |
| 20110004106 | Iwamiya et al. | Jan 2011 | A1 |
| 20110021897 | Webb et al. | Jan 2011 | A1 |
| 20110066039 | Banet et al. | Mar 2011 | A1 |
| 20110066049 | Matsumoto | Mar 2011 | A1 |
| 20110066062 | Banet et al. | Mar 2011 | A1 |
| 20110098933 | Ochs | Apr 2011 | A1 |
| 20110105860 | Houben et al. | May 2011 | A1 |
| 20110105926 | Kornet | May 2011 | A1 |
| 20110124979 | Heneghan | May 2011 | A1 |
| 20110125040 | Crawford et al. | May 2011 | A1 |
| 20110144470 | Mazar et al. | Jun 2011 | A1 |
| 20110158284 | Goto | Jun 2011 | A1 |
| 20110160604 | Istvan et al. | Jun 2011 | A1 |
| 20110166434 | Gargiulo | Jul 2011 | A1 |
| 20110166468 | Prystowsky et al. | Jul 2011 | A1 |
| 20110190598 | Shusterman | Aug 2011 | A1 |
| 20110194007 | Kim et al. | Aug 2011 | A1 |
| 20110208076 | Fong et al. | Aug 2011 | A1 |
| 20110208078 | Cho et al. | Aug 2011 | A1 |
| 20110263994 | Burns | Oct 2011 | A1 |
| 20110270049 | Katra et al. | Nov 2011 | A1 |
| 20110270112 | Manera et al. | Nov 2011 | A1 |
| 20110279963 | Kumar | Nov 2011 | A1 |
| 20110301445 | Webb et al. | Dec 2011 | A9 |
| 20110301493 | Husheer | Dec 2011 | A1 |
| 20120016245 | Niwa et al. | Jan 2012 | A1 |
| 20120029306 | Paquet | Feb 2012 | A1 |
| 20120029320 | Watson et al. | Feb 2012 | A1 |
| 20120035490 | Shen et al. | Feb 2012 | A1 |
| 20120035494 | Chakravarthy et al. | Feb 2012 | A1 |
| 20120061695 | Kim | Mar 2012 | A1 |
| 20120071744 | Euliano et al. | Mar 2012 | A1 |
| 20120083673 | Al-Ali et al. | Apr 2012 | A1 |
| 20120101396 | Solosko et al. | Apr 2012 | A1 |
| 20120108917 | Libbus et al. | May 2012 | A1 |
| 20120108920 | Bly et al. | May 2012 | A1 |
| 20120109572 | Shimizu | May 2012 | A1 |
| 20120110226 | Mach et al. | May 2012 | A1 |
| 20120110228 | Mach et al. | May 2012 | A1 |
| 20120136226 | Wilke | May 2012 | A1 |
| 20120143079 | Lia et al. | Jun 2012 | A1 |
| 20120176599 | Leung | Jul 2012 | A1 |
| 20120197150 | Cao et al. | Aug 2012 | A1 |
| 20120203077 | He et al. | Aug 2012 | A1 |
| 20120204068 | Ye et al. | Aug 2012 | A1 |
| 20120226129 | Callahan et al. | Sep 2012 | A1 |
| 20120232369 | Kim et al. | Sep 2012 | A1 |
| 20120245951 | Gips et al. | Sep 2012 | A1 |
| 20120277549 | Libbus et al. | Nov 2012 | A1 |
| 20120284003 | Gosh | Nov 2012 | A1 |
| 20120289839 | Takenoshita | Nov 2012 | A1 |
| 20120330126 | Hoppe | Dec 2012 | A1 |
| 20120330151 | Weinstein et al. | Dec 2012 | A1 |
| 20130012938 | Asirvatham | Jan 2013 | A1 |
| 20130030257 | Nakata | Jan 2013 | A1 |
| 20130030259 | Thomsen et al. | Jan 2013 | A1 |
| 20130085347 | Manicka et al. | Apr 2013 | A1 |
| 20130085708 | Sattler | Apr 2013 | A1 |
| 20130096395 | Katra et al. | Apr 2013 | A1 |
| 20130116520 | Roham | May 2013 | A1 |
| 20130116534 | Woo | May 2013 | A1 |
| 20130116585 | Bouguerra | May 2013 | A1 |
| 20130144130 | Russell et al. | Jun 2013 | A1 |
| 20130158372 | Haisley | Jun 2013 | A1 |
| 20130172724 | Aziz et al. | Jul 2013 | A1 |
| 20130225938 | Mach | Aug 2013 | A1 |
| 20130245388 | Rafferty et al. | Sep 2013 | A1 |
| 20130245415 | Kumar et al. | Sep 2013 | A1 |
| 20130253285 | Bly et al. | Sep 2013 | A1 |
| 20130261422 | Gilmore et al. | Oct 2013 | A1 |
| 20130267854 | Johnson et al. | Oct 2013 | A1 |
| 20130296660 | Tsien | Nov 2013 | A1 |
| 20130296823 | Melker | Nov 2013 | A1 |
| 20130324812 | Brainard | Dec 2013 | A1 |
| 20130324816 | Bechtel et al. | Dec 2013 | A1 |
| 20130324855 | Lisogurski | Dec 2013 | A1 |
| 20130331665 | Libbus et al. | Dec 2013 | A1 |
| 20130338448 | Libbus et al. | Dec 2013 | A1 |
| 20130338460 | He et al. | Dec 2013 | A1 |
| 20140038147 | Morrow | Feb 2014 | A1 |
| 20140066726 | Costello | Mar 2014 | A1 |
| 20140066732 | Addison et al. | Mar 2014 | A1 |
| 20140066783 | Kiani et al. | Mar 2014 | A1 |
| 20140081152 | Clinton | Mar 2014 | A1 |
| 20140091926 | Gips et al. | Apr 2014 | A1 |
| 20140100432 | Golda et al. | Apr 2014 | A1 |
| 20140121557 | Gannon et al. | May 2014 | A1 |
| 20140206976 | Thompson | Jul 2014 | A1 |
| 20140228656 | Gonopolskiy et al. | Aug 2014 | A1 |
| 20140275869 | Kintz et al. | Sep 2014 | A1 |
| 20140276089 | Kirenko et al. | Sep 2014 | A1 |
| 20150057511 | Basu | Feb 2015 | A1 |
| 20150087948 | Bishay et al. | Mar 2015 | A1 |
| 20150087951 | Felix et al. | Mar 2015 | A1 |
| 20150094551 | Frix et al. | Apr 2015 | A1 |
| 20150094552 | Golda et al. | Apr 2015 | A1 |
| 20150148622 | Moyer et al. | May 2015 | A1 |
| 20150148637 | Golda et al. | May 2015 | A1 |
| 20150148691 | Moyer et al. | May 2015 | A1 |
| 20150335288 | Toth et al. | Nov 2015 | A1 |
| 20150351690 | Toth et al. | Dec 2015 | A1 |
| 20160073954 | Meitav | Mar 2016 | A1 |
| 20160238440 | Chu et al. | Aug 2016 | A1 |
| 20160302674 | Moyer et al. | Oct 2016 | A1 |
| 20160345881 | Sarantos et al. | Dec 2016 | A1 |
| 20170027513 | Mulpuru | Feb 2017 | A1 |
| 20170095156 | Richards | Apr 2017 | A1 |
| 20170337412 | Bhat et al. | Nov 2017 | A1 |
| 20170337413 | Bhat et al. | Nov 2017 | A1 |
| 20180028122 | Golda et al. | Feb 2018 | A1 |
| 20180085068 | Telfort | Mar 2018 | A1 |
| 20180177459 | Eletr et al. | Jun 2018 | A1 |
| 20180325385 | Deterding et al. | Nov 2018 | A1 |
| 20190029599 | Golda et al. | Jan 2019 | A1 |
| 20190282096 | Vardi | Sep 2019 | A1 |
| 20190320914 | Moyer et al. | Oct 2019 | A1 |
| 20200008749 | Golda et al. | Jan 2020 | A1 |
| 20200229767 | Eletr et al. | Jul 2020 | A1 |
| 20200237309 | Golda et al. | Jul 2020 | A1 |
| 20210059586 | Marriott et al. | Mar 2021 | A1 |
| 20210100514 | Golda et al. | Apr 2021 | A1 |
| 20210145293 | Van Zandt Moyer et al. | May 2021 | A1 |
| 20210236064 | Van Zandt Moyer et al. | Aug 2021 | A1 |
| Number | Date | Country |
|---|---|---|
| 2785556 | Jun 2006 | CN |
| 101822533 | Sep 2010 | CN |
| 201641985 | Nov 2010 | CN |
| 101984743 | Mar 2011 | CN |
| 102215747 | Oct 2011 | CN |
| 202288274 | Jul 2012 | CN |
| 105997103 | Oct 2016 | CN |
| 104812296 | May 2018 | CN |
| 0581073 | Feb 1994 | EP |
| 1737337 | May 2005 | EP |
| 1139858 | Apr 2007 | EP |
| 2438851 | Apr 2012 | EP |
| 2305103 | Sep 2013 | EP |
| 2903509 | Sep 2019 | EP |
| 3636148 | Apr 2020 | EP |
| 3099224 | May 2020 | EP |
| 3636148 | May 2020 | EP |
| 3769669 | Jan 2021 | EP |
| 52-052494 | Apr 1977 | JP |
| 52052494 | Apr 1977 | JP |
| 02172443 | Jul 1990 | JP |
| H05123305 | May 1993 | JP |
| H07213630 | Aug 1995 | JP |
| H09224917 | Sep 1997 | JP |
| 2001029318 | Feb 2001 | JP |
| 2001078974 | Mar 2001 | JP |
| 2002125944 | May 2002 | JP |
| 2002263075 | Sep 2002 | JP |
| 2004000474 | Jan 2004 | JP |
| 2004016248 | Jan 2004 | JP |
| 2006000481 | Jan 2006 | JP |
| 2006158813 | Jun 2006 | JP |
| 3952082 | Aug 2007 | JP |
| 2007244531 | Sep 2007 | JP |
| 2007296266 | Nov 2007 | JP |
| 2011147746 | Aug 2011 | JP |
| 20120187404 | Oct 2012 | JP |
| 5408751 | Feb 2014 | JP |
| 6298063 | Mar 2018 | JP |
| 6539827 | Jul 2019 | JP |
| 6625682 | Dec 2019 | JP |
| 2020513876 | May 2020 | JP |
| W09401039 | Jan 1994 | WO |
| WO9427494 | Dec 1994 | WO |
| WO0045696 | Aug 2000 | WO |
| WO0059374 | Oct 2000 | WO |
| WO01043624 | Jun 2001 | WO |
| WO2001085019 | Nov 2001 | WO |
| WO2001093758 | Dec 2001 | WO |
| W00200094 | Jan 2002 | WO |
| WO2002085201 | Oct 2002 | WO |
| WO2002086792 | Oct 2002 | WO |
| WO2002086835 | Oct 2002 | WO |
| WO2002086837 | Oct 2002 | WO |
| WO2003077752 | Sep 2003 | WO |
| WO2005079429 | Jan 2005 | WO |
| WO2005060829 | Jul 2005 | WO |
| WO2005072237 | Aug 2005 | WO |
| W02006014806 | Feb 2006 | WO |
| WO2006044919 | Apr 2006 | WO |
| WO2006110488 | Oct 2006 | WO |
| W02006124788 | Nov 2006 | WO |
| WO2006124788 | Nov 2006 | WO |
| 2008092098 | Jul 2008 | WO |
| WO2008092098 | Jul 2008 | WO |
| WO2008092098 | Oct 2008 | WO |
| WO2009036321 | Mar 2009 | WO |
| WO2009036327 | Mar 2009 | WO |
| 2009112972 | Sep 2009 | WO |
| WO2010055155 | May 2010 | WO |
| WO2010093900 | Aug 2010 | WO |
| WO2010104952 | Sep 2010 | WO |
| WO2010107913 | Sep 2010 | WO |
| W02011074004 | Jun 2011 | WO |
| WO2012104658 | Aug 2012 | WO |
| WO2012129498 | Sep 2012 | WO |
| WO2012150563 | Nov 2012 | WO |
| 2014027293 | Feb 2014 | WO |
| 2014027293 | Feb 2014 | WO |
| 2014055994 | Apr 2014 | WO |
| 2015113054 | Jul 2015 | WO |
| WO2013071014 | May 2016 | WO |
| 2016210334 | Dec 2016 | WO |
| WO2018112401 | Jun 2018 | WO |
| 2020154697 | Jul 2020 | WO |
| Entry |
|---|
| Extended European Search Report for Application No. EP19194996 issued by the European Patent Office, dated Apr. 22, 2020, 18 pages, EPO, Munich, Germany. |
| Palreddy, Surekha, Chapter 9—Signal Processing Algorithms, Design of Pulse Oximeters, Medical Science Series, Bristol [U.A.]; Institute of Physics Pub, GB, Jan. 1, 1997, pp. 124-158, 133-157, Taylor & Francis Group, LLC., New York, NY and Milton Park, Abingdon, Oxon, England. |
| International Search Report and Written Opinion of the International Searching Authority. International Application No. PCT/US20/15099 issued by the United State Patent Office, dated Jun. 4, 2020, 11 pages, Alexandria Virginia. |
| Yoo, Jerald et al., A 5.2 mW Self-Configured Wearable Body Sensor Network controller and a 12 uW Wirelessly Powered Sensor for a Continuous Health Monitoring System, IEEE Journal of Solid-State Circuits, Jan. 2010, pp. 178-188, vol. 45, Issue No. 1, Institute of Electrical and Electronics Engineers, Piscataway, NJ. |
| Partial European Search Report for Application No. 19194996.5 issued by the European Patent Office, dated Feb. 6, 2020, 15 pages, EPO, Munich, Germany. |
| Extended European Search Report including the Supplementary European Search Report (SESR) for Application No. EP13843561.5 issued by the European Patent Office, Munich, Germany dated Apr. 29, 2016. |
| Kadota, Hiroshi, Japanese Patent Office, Japanese Office Action dated Nov. 30, 2021 for Japanese Application No. 2020-218861, original 3 pages, and translation 3 pages; Japanese Patent Office. |
| Supplementary European Search Report for Application No. EP16815429 issued by the European Patent Office, dated Jan. 17, 2019, 4 pages, EPO, Munich, Germany. |
| Allen, John, Photoplethysmography and its application in clinical physiological measurement, Physiological Measurement, Feb. 20, 2007, pp. R1-R39, vol. 28, No. 3, IOP Publishing Ltd., Bristol, United Kingdom. |
| International Search Report and Written Opinion of the International Searching Authority. International Application No. PCT/US2016/039374 issued by the United State Patent Office, dated Oct. 28, 2016, 14 pages, Alexandria Virginia. (needs to be cited 101, 201, 301, 401, 701). |
| International Search Report and Written Opinion of the International Searching Authority. International Application No. PCT/US2013/063748 issued by the United State Patent Office, dated Feb. 27, 2014, 15 pages, Alexandria Virginia. |
| Timmerman, Luke, Xconomy, Inc., “UW Spinout Cardiac Insight Wins FDA OK for Heartbeat Monitor”, published Jun. 6, 2013; website accessed Oct. 27, 2013, http://www.xconomy.com/seattle/2013/06/06/uw-spinout-cardiac-insight-wins-fda-ok-for-heartbeat-monitor/, Xconomy Inc., Cambridge, Massachusetts. |
| CardioNet, Inc., “CardioNet, Inc. Announces Launch of MCOTos 2:1 Device”, published Jun. 19, 2013; website accessed Oct. 27, 2013, https://www.cardionet.com/index.htm, BioTelemetry, Inc., Conshohocken, Pennsylvania. |
| Heart Check, “The HeartCheck Pen, a Handheld ECG with Smart Monitoring”, website accessed Oct. 27, 2013, http://heartcheckpen.com/, HeartCheckPEN.com, TAW Global, LLC, Portage, Michigan; CardioComm Solutions Inc., Toronto, ON, and Victoria, BC. |
| Corventis, Inc., “Nuvant Mobile Cardiac Telemetry”, Copyright 2009-2013; website accessed Oct. 27, 2013, http://corventis.com/, Corventis, San Jose, California. |
| Transmittal of International Preliminary Report on Patentability dated of Apr. 16, 2015 and International Preliminary Report on Patentability dated Apr. 7, 2015 with Written Opinion of the International Searching Authority International Application No. PCT/US2013/063748 issued by the United State Patent Office, dated Feb. 27, 2014, 5 pages, Alexandria, Virginia. |
| International Search Report and Written Opinion of the International Searching Authority. International Application No. PCT/US2015/13113 issued by the United State Patent Office, dated Jun. 29, 2015, 14 pages, Alexandria Virginia. |
| Kansy, Robert J., Response of a Correlated Double Sampling Circuity to 1/f Noise, IEEE Journal of Solid-State Circuits, Jun. 1980, pp. 373-375, vol. SC-15, No. 3, IEEE, New York, NY, USA. |
| Chinese Office Action, Application No. 201780077645.7, dated Jun. 15, 2021, China National Intellectual Property Administration, Beijing, China. |
| International Search Report and Written Opinion of the International Searching Authority. International Application No. PCT/US2020/048603 issued by the United States Patent Office, dated Jan. 4, 2020, 18 pages, USPTO, Alexandria, Virginia, USA. |
| Supplementary European Search Report for Application No. EP17880188 issued by the European Patent Office, dated Aug. 5, 2020, 8 pages, EPO, Munich, Germany. |
| Extended European Search Report for Application No. EP20175192 issued by the European Patent Office, dated Oct. 26, 2020, 12 pages, EPO, Munich, Germany. |
| Japanese Office Action dated Aug. 31, 2021 for Japanese Application No. 2019531741—original and translation. |
| PDF “Dictionary_composite” from https://www.merriam-webster.com/dictionary/composite accessed on Feb. 12, 2019 (Year:2019). |
| Extended European Search Report including the Supplementary European Search Report for Application No. EP15740972 issued by the European Patent Office, Munich, Germany dated Aug. 29, 2017. |
| Notification of transmiital of the International Search Report and the Written Opinion of the International Searching Authority for Application No. PCT/US2017/066805 issued by the International Searching Authority, Alexandria, VA dated Mar. 12, 2018, 1 page, which includes: The International Search Report completed Feb. 7, 2018 dated Mar. 12, 2018, 5 pages, with Written Opinion of the International Searching Authority for International Application No. PCT/US2017/066805 dated Mar. 12, 2018 issued by the United States Patent Office, Alexandria, Virginia, US. |
| Transmittal of International Preliminary Report of Patentability and International Preliminary Report on Patentability for Application No. PCT/US2016/039374 issued by the International Bureau of WIPO, Geneva, Switzerland dated Jan. 4, 2018 which includes: The International Preliminary Report on Patentability dated Dec. 26, 2017 with Written Opinion of the International Searching Authority for International Application No. PCT/US2016/039374 dated Oct. 28, 2016 issued by the United States Patent Office, Alexandria, Virginia, US. |
| Number | Date | Country | |
|---|---|---|---|
| 20210212638 A1 | Jul 2021 | US |
| Number | Date | Country | |
|---|---|---|---|
| 62038768 | Aug 2014 | US | |
| 62008959 | Jun 2014 | US | |
| 62000975 | May 2014 | US | |
| 61932100 | Jan 2014 | US | |
| 61932094 | Jan 2014 | US | |
| 61710768 | Oct 2012 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 15728215 | Oct 2017 | US |
| Child | 17216348 | US | |
| Parent | 14565412 | Dec 2014 | US |
| Child | 15728215 | US | |
| Parent | 13837748 | Mar 2013 | US |
| Child | PCT/US2013/063748 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | PCT/US2013/063748 | Oct 2013 | US |
| Child | 14565412 | US | |
| Parent | 13837748 | Mar 2013 | US |
| Child | 14565412 | US |
